WOCKPHARMA - Swing Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Swing Trade Rating: 3.1

📊 Analysis Summary

Wockhardt Ltd (WOCKPHARMA) presents a high-risk, high-reward swing trade setup. While technical indicators suggest short-term momentum, the fundamentals are weak, with negative earnings and poor profitability. This stock may appeal to aggressive traders looking for a speculative bounce, but caution is essential.

✅ Positives

Technical Momentum

MACD: +12.7 — strong bullish crossover.

RSI: 49.1 — neutral zone, close to bullish territory.

Price above DMA 50 (₹1,644) and DMA 200 (₹1,383) — bullish structure.

Institutional Interest

FII Holding ↑ 0.47% and DII Holding ↑ 0.42% — growing confidence.

52W Index: 83.3%

Strong relative strength — outperforming peers.

⚠️ Weaknesses

Fundamentals

ROCE: 3.75% & ROE: –1.22% — poor efficiency and negative returns.

EPS: –₹2.89 — loss-making.

PAT Qtr: –₹25 Cr. vs ₹14 Cr. — sharp earnings reversal.

Dividend Yield: 0.00% — no income support.

Valuation Metrics Missing

No P/E or PEG Ratio — difficult to assess valuation.

Volume Decline

Current volume (4.24L) < Avg volume (5.67L) — waning interest.

Debt Load

Debt to Equity: 0.46 — moderate leverage.

🎯 Optimal Entry Price

Entry Zone: ₹1,660–₹1,680

Near DMA 50 — low-risk entry if momentum continues.

Confirmation Needed

RSI > 52 and sustained MACD strength with volume spike.

🚪 Exit Strategy (If Already Holding)

Exit Target: ₹1,780–₹1,820

Near recent resistance — ideal for profit booking.

Stop Loss: ₹1,620

Below DMA 50 — protects against reversal.

Would you like to explore pharma stocks with stronger earnings and lower debt for safer swing trade setups?

Edit in a page